Arcellx, Inc. Common Stock (ACLX) is a publicly traded Healthcare sector company. As of May 20, 2026, ACLX trades at $115.07 with a market cap of $6.73B and a P/E ratio of -28.27. ACLX moved +0.03% today. Year to date, ACLX is +62.44%; over the trailing twelve months it is +80.62%. Its 52-week range spans $47.86 to $115.13. Analyst consensus is hold with an average price target of $112.45. Rallies surfaces ACLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Arcellx, Inc. Common Stock (ACLX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ACLX moved +0.03% today. Analyst consensus is hold.
| Metric | Value |
|---|---|
| Price | $115.07 |
| Market Cap | $6.73B |
| P/E Ratio | -28.27 |
| EPS | $-4.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $115.13 |
| 52-Week Low | $47.86 |
| Volume | 16.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $22.29M |
| Net Income | $-228.93M |
| Gross Margin | 0.00% |
18 analysts cover ACLX: 0 strong buy, 7 buy, 11 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $112.45.